title: Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia.
authors.affiliation: Division of Hematology and Oncology, University Hospital of Leipzig, 04103, Leipzig, Germany.
authors.forename: Song-Yau
authors.initials: SY
authors.lastname: Wang
authors.forename: Thomas
authors.initials: T
authors.lastname: Ebert
authors.forename: Nadja
authors.initials: N
authors.lastname: Jaekel
authors.forename: Stefan
authors.initials: S
authors.lastname: Schubert
authors.forename: Dietger
authors.initials: D
authors.lastname: Niederwieser
authors.forename: Haifa Kathrin
authors.initials: HK
authors.lastname: Al-Ali
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010880:Piperidines; D011720:Pyrazoles / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D014391:Tuberculosis, Miliary / Q000139:chemically induced* / Q000175:diagnosis*
chemical_list: D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine